⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Autoimmune CAR T Safety Events Reshape Rheumatologist Sentiment, but Autologous CAR T Retains Lead, According to Spherix Global Insights
globenewswire.com
NVS
BMY
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
prnewswire.com
NVS
American Kidney Fund and IgA Nephropathy Foundation Advocate on Capitol Hill for Rare Kidney Disease Legislation
globenewswire.com
AMGN
VRTX
NVS
Atherosclerotic Cardiovascular Disease (ASCVD) Market Insights, Epidemiology, and Forecast - 2036 | 7MM Market to Reach USD 40 Billion as Precision Therapies Reshape Growth
globenewswire.com
AMGN
ARWR
NVS
ALNY
SNY
REGN
ESPR
JNJ
AZN
AMRN
MRK
LLY
BMY
ON
NVO
Global Drug Discovery Market (2026-2031) - AI-Driven Target Identification Accelerates Growth
globenewswire.com
NVDA
LLY
CHAI
TMO
ABBV
AMGN
AZN
BDX
BMY
CRL
JNJ
MRK
NVS
PFE
REGN
SNY
VRTX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
accessnewswire.com
NVS
Drug Repurposing Market - Global Strategic Business Report: Forecasts Growth to $37.3Billion by 2030, Profiling AbbVie, AstraZeneca, Pfizer, Novartis & Johnson & Johnson
globenewswire.com
ABBV
AZN
PFE
NVS
JNJ
AMGN
BMY
GILD
BIIB
TXMD
UTHR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
globenewswire.com
NVS
Novartis AG (NVS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
accessnewswire.com
NVS
CAS announces collaboration with Novartis to advance AI-ready reaction informatics
prnewswire.com
NVS